FIELD: medicine.
SUBSTANCE: invention relates to rheumatology, namely to a method for predicting the activity of the disease in patients with rheumatoid arthritis (RA). To do this, the level of chemerin in the blood serum is examined. When the serum concentration of chemerin is higher than 257.3 ng/ml, high activity of the disease is predicted, at its values of 257.3 ng/ml and lower, moderate activity of the disease is predicted.
EFFECT: invention makes it possible to improve the quality of diagnosis of the disease in RA patients.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF HIP FRACTURES IN FEMALES WITH RHEUMATOID ARTHRITIS | 2019 |
|
RU2731844C1 |
| PREDICTION PROCEDURE OF SIMVASTATIN BASED CLINICAL EFFECTIVENESS WITH REGARD TO RHEUMATOID ARTHRITIS | 2008 |
|
RU2367430C1 |
| METHOD FOR ARTERIAL RIGIDITY CORRECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2016 |
|
RU2623082C1 |
| METHOD FOR PREDICTION OF EFFICACY OF INFLIXIMAB INCLUSION IN THERAPY OF PATIENTS WITH RHEUMATOID ARTHRITIS | 2010 |
|
RU2416799C1 |
| METHOD FOR PREDICTION OF LOW-ENERGY BONE FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2018 |
|
RU2702611C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF RHEUMATOID ARTHRITIS WITH DRUG OLOKIZUMAB USING EPIGENETIC MARKERS | 2020 |
|
RU2749248C1 |
| METHOD OF VASOMOTOR ENDOTHELIAL DYSFUNCTION CORRECTION AND ARTERIAL RIGIDITY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2018 |
|
RU2696285C1 |
| METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
| METHOD OF ESTIMATING SEVERITY OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2536294C1 |
| METHOD FOR DIAGNOSING ANEMIA OF CHRONIC DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2021 |
|
RU2783248C1 |
